These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38056905)

  • 41. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma Treatment.
    Fu Y; He G; Liu Z; Wang J; Li M; Zhang Z; Bao Q; Wen J; Zhu X; Zhang C; Zhang W
    Small; 2022 Jul; 18(30):e2202337. PubMed ID: 35780479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Red Blood Cell Membrane Camouflaged Mesoporous Silica Nanorods as Nanocarriers for Synergistic Chemo-Photothermal Therapy.
    Zong S; Cao C; Chen K; Cui Y; Li J; Wang Z
    IEEE Trans Nanobioscience; 2023 Jul; 22(3):655-663. PubMed ID: 37015652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
    Zhang Y; Zhang P; Zhu T
    Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Light-activatable Chlorin e6 (Ce6)-imbedded erythrocyte membrane vesicles camouflaged Prussian blue nanoparticles for synergistic photothermal and photodynamic therapies of cancer.
    Sun L; Li Q; Hou M; Gao Y; Yang R; Zhang L; Xu Z; Kang Y; Xue P
    Biomater Sci; 2018 Oct; 6(11):2881-2895. PubMed ID: 30192355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long Circulating Cancer Cell-Targeted Bionic Nanocarriers Enable Synergistic Combinatorial Therapy in Colon Cancer.
    Zheng Y; Guo W; Hu L; Xiao Z; Yang X; Cao Z; Cao J
    ACS Appl Mater Interfaces; 2023 May; 15(19):22843-22853. PubMed ID: 37133278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer.
    Yang Y; Liu Q; Wang M; Li L; Yu Y; Pan M; Hu D; Chu B; Qu Y; Qian Z
    Signal Transduct Target Ther; 2024 Jun; 9(1):158. PubMed ID: 38862461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.
    Marshall SK; Angsantikul P; Pang Z; Nasongkla N; Hussen RSD; Thamphiwatana SD
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
    Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
    Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocyte membrane-camouflaged DNA-functionalized upconversion nanoparticles for tumor-targeted chemotherapy and immunotherapy.
    Kou Q; Huang Y; Su Y; Lu L; Li X; Jiang H; Huang R; Li J; Nie X
    Nanoscale; 2023 Jun; 15(21):9457-9476. PubMed ID: 37161583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PEGylated WS
    Long Y; Wu X; Li Z; Fan J; Hu X; Liu B
    Biomater Sci; 2020 Sep; 8(18):5088-5105. PubMed ID: 32812542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy.
    Domínguez-Ríos R; Sánchez-Ramírez DR; Ruiz-Saray K; Oceguera-Basurto PE; Almada M; Juárez J; Zepeda-Moreno A; Del Toro-Arreola A; Topete A; Daneri-Navarro A
    Colloids Surf B Biointerfaces; 2019 Jun; 178():199-207. PubMed ID: 30856589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
    Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers.
    Song M; Dong S; An X; Zhang W; Shen N; Li Y; Guo C; Liu C; Li X; Chen S
    J Control Release; 2022 May; 345():744-754. PubMed ID: 35381274
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.
    Xia Q; Zhang Y; Li Z; Hou X; Feng N
    Acta Pharm Sin B; 2019 Jul; 9(4):675-689. PubMed ID: 31384529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy.
    Xie X; Wang H; Williams GR; Yang Y; Zheng Y; Wu J; Zhu LM
    Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31450749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release.
    Aryal S; Hu CM; Fang RH; Dehaini D; Carpenter C; Zhang DE; Zhang L
    Nanomedicine (Lond); 2013 Aug; 8(8):1271-80. PubMed ID: 23409747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.